Pre-market hot trades in US stocks: Gaxos.ai pre-market down 12.70%; Reddit pre-market up 12.46%

Pre-market Hot Trades in US Stocks

Gaxos.ai is down 12.70% in pre-market trading. Based on recent news,

1. On August 13, Gaxos.ai's Relative Strength Index (RSI) was 39.25, indicating that the stock is in an oversold state. Over the past 12 months, the stock has fallen by 19.40% and is currently close to its 52-week low, showing a negative price trend. Source: Benzinga

2. On August 13, Gaxos.ai released its second-quarter financial report, showing cash and short-term investments of $44 million. The CEO stated that the scalability of the company's operating platform and the discipline in capital allocation are evident. Despite improvements in advertising efficiency, the stock price still declined. Source: Benzinga

3. On August 12, Gaxos.ai issued a forward-looking statement emphasizing that the company's views may change and it does not undertake the obligation to update statements. This uncertainty may affect investor confidence. Source: Company website. The technology sector has recently shown weak performance, with significant capital outflows.

Reddit is up 12.46% in pre-market trading. Based on recent key news:

1. On August 14, Reddit was included in the S&P 500 Index, and its stock price rose 12.45% after hours. This move will take effect on August 18, replacing AvalonBay Communities, making it the second pure social media company in the index. This news has stimulated the stock price increase, showing market optimism about its future performance. Source: Jinse Finance

2. On August 14, Reddit announced its second-quarter financial report, with revenue increasing by 61% year-over-year to $805 million, achieving over 60% growth for eight consecutive quarters. The strong financial performance has boosted investor confidence. Source: Jinse Finance

3. On August 14, concerns about Reddit's reliance on Google for acquiring new users have intensified. The company acknowledged in its earnings call that fluctuations in search referral traffic have put pressure on the stock price. Source: Jinse Finance. Technology stocks are rising, and expectations for improved inflation are increasing.

Top Gainers in Pre-market US Stocks

Capricor Therapeutics is up 100.24% in pre-market trading. Based on recent key news:

1. On August 14, Capricor Therapeutics reported a net loss of $40.7 million for the second quarter, with a loss of $0.70 per share, leading to significant stock price volatility. The company's cash and cash equivalents decreased from $318.1 million to $237.9 million. Source: Reuters

2. On August 14, Capricor Therapeutics is facing a lawsuit for violating the blinding and protocol of the HOPE-3 trial, increasing legal risks. Source: PR Newswire

3. On August 13, whistleblowers suggested that individuals with non-public information consider participating in investigations or utilizing the SEC whistleblower program, further exacerbating market uncertainty. Source: Hagens Berman. The biotechnology sector has recently shown weak performance, with increased regulatory risks Akanda pre-market up 90.42%. Based on recent news:

4. On August 13, Akanda Corporation released the latest content, emphasizing that its stock price has fallen 94.80% over the past year and is currently close to its annual low. This information may trigger market attention on its future performance, leading to stock price fluctuations.

5. On August 14, Benzinga's technical analysis showed that Akanda's Relative Strength Index (RSI) is 29.27, indicating that its stock has a negative price trend across all time frames. This technical indicator may affect investor sentiment, leading to stock price fluctuations.

6. On August 14, FTF Company updated the operational status of its 28 active cellular tower sites, marking an important step towards recurring revenue growth. Although not directly related to Akanda, positive dynamics in the industry may indirectly influence investor confidence in Akanda. Market volatility is increasing, and industry dynamics need to be monitored.

China Su Xuan Tang Pharmaceutical pre-market up 60%. Based on recent key news:

1. On August 11, China Su Xuan Tang Pharmaceutical announced a 1-for-80 reverse stock split to meet Nasdaq's minimum bid requirements. This move aims to increase the stock price, restore market confidence, and drive the stock price up.

2. On August 11, the company plans a multi-million dollar direct offering in early 2026 and attempts to integrate AI analysis into its R&D pipeline. This move demonstrates the company's proactive efforts in technological innovation, attracting investor attention.

3. No other significant news recently. The traditional Chinese medicine industry faces challenges, and policy changes need to be monitored